OUR NEWS - FAST TRACK EVALUATION SERVICE
19
Mar
The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease
The CHUS Ranks First in the World for a Sanofi Study on a Rare Inflammatory Disease The team lead by Dr. Hugues Allard-Chamard at the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) stood out on the international stage by becoming the first site worldwide to be activated, ahead of 97 other sites in 19 countries, for